(Q42676474)

4 November 2017

title

The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers (English)

1 reference

4 November 2017

1 reference

1 reference

Katy H P Moore

1

1 reference

4 November 2017

Philip T Leese

2

1 reference

4 November 2017

Scott McNeal

3

1 reference

4 November 2017

Peter Gray

4

1 reference

4 November 2017

Stephen O'Quinn

5

1 reference

4 November 2017

Carole Bye

6

1 reference

4 November 2017

Mark Sale

7

1 reference

4 November 2017

publication date

1 April 2002

1 reference

4 November 2017

published in

Clinical Therapeutics

1 reference

4 November 2017

volume

24

1 reference

4 November 2017

issue

4

1 reference

4 November 2017

page(s)

583-594

1 reference

Sumatriptan. An updated review of its use in migraine

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

The Clinical Pharmacology, Pharmacokinetics and Metabolism of Sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Sumatriptan clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Single dose pharmacokinetics of sumatriptan in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Drug interactions of macrolides: emphasis on dirithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Macrolides versus azalides: a drug interaction update

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over Design

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

Clarithromycin clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985134-7

7 January 2021

10.1016/S0149-2918(02)85134-7

Identifiers

DOI

1 reference

4 November 2017

1 reference